Jennifer Petts, DO
Allergy & Immunology · West Des Moines, IANPI 1144455502
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $129 of the $163 with a category attached, or 79.1%. 6 manufacturers reported payments, led by Bio Products Laboratory USA, Inc. at 28.2% of the total. 2025 is the largest year on record at $56, 2.9 times the $20 reported in 2022. That places this record below the midpoint for allergy & immunology clinicians in IA, where the typical reported total is $750.
Across 9 payments — averaging $18.07 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Bio Products Laboratory USA, Inc.$46
- Amgen$34
- Kedrion Biopharma, Inc.$24
- Genentech USA, Inc.$22
- Novo Nordisk$20
- Regeneron Healthcare Solutions, Inc.$17
Across 19 payments — averaging $33,184 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Modernatx, Inc.$607K
- AstraZeneca$23K
What the payments were for
- Food & beverage$12979%
- Education$3421%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Bio Products Laboratory USA, Inc. | 4 | $46 |
| Amgen | 1 | $34 |
| Kedrion Biopharma, Inc. | 1 | $24 |
| Genentech USA, Inc. | 1 | $22 |
| Novo Nordisk | 1 | $20 |
| Regeneron Healthcare Solutions, Inc. | 1 | $17 |
How this compares
$163 in reported general payments places this provider in the 20th percentile of 32 allergy & immunology providers in Iowa.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Dupixent PenDupilumab | 66 | $316,243 |
| HizentraImmun Glob G(Igg)/Pro/Iga 0-50 | 38 | $256,243 |
| NucalaMepolizumab | 15 | $112,551 |
| XolairOmalizumab | 27 | $73,528 |
| Epinephrine | 69 | $12,330 |
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 19 | $11,791 |
| Ipratropium Bromide | 359 | $8,566 |
| Breo ElliptaFluticasone/Vilanterol | 21 | $8,442 |
| Azelastine Hcl | 181 | $6,201 |
| Olopatadine Hcl | 62 | $5,028 |
| Montelukast Sodium | 542 | $3,426 |
| AlvescoCiclesonide | 11 | $3,036 |
| Cromolyn Sodium | 12 | $2,455 |
| Fluticasone-SalmeterolFluticasone Propion/Salmeterol | 13 | $1,652 |
| Hydroxyzine Hcl | 41 | $737 |
Paid to pharmacies, not to this prescriber.
Other allergy & immunology in West Des Moines
- Vuong NayimaWest Des Moines$34K
- Fadi AlkhatibWest Des Moines$16K
- Ravinder AgarwalWest Des Moines$2K
- Ahmad AlshashWest Des Moines$872
- Daniel HamilosMason City$11K
- Lyla SchweigerCedar Rapids$6K
- Edward NassifAmes$5K
- Holly BrownCedar Rapids$4K
- Whitney MolisDes Moines$4K
- Safia NawazDes Moines$4K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.